https://gmasoln.comGLOBAL MARKET ACCESS SOLUTIONS DEFINING VALUE IN HEALTHCARE https://gmasoln.com/members/zlatko-boni/https://gmasoln.com/members/zlatko-boni/Wed, 08 Oct 2025 19:11:57 +0000 https://gmasoln.com/members/dilyana-dimitrova/https://gmasoln.com/members/dilyana-dimitrova/Mon, 22 Sep 2025 19:37:32 +0000 https://gmasoln.com/members/stephen-tearoe-m-a/https://gmasoln.com/members/stephen-tearoe-m-a/Mon, 22 Sep 2025 19:28:49 +0000 https://gmasoln.com/members/cillian-copeland/https://gmasoln.com/members/cillian-copeland/Sat, 15 Feb 2025 16:19:21 +0000 https://gmasoln.com/members/carina-schey/https://gmasoln.com/members/carina-schey/Sat, 15 Feb 2025 14:37:47 +0000 https://gmasoln.com/members/zrinka-orlovic-msc/https://gmasoln.com/members/zrinka-orlovic-msc/Thu, 19 Oct 2023 15:39:29 +0000 https://gmasoln.com/members/nikos-kotsopoulos/https://gmasoln.com/members/nikos-kotsopoulos/Thu, 19 Oct 2023 15:15:51 +0000 https://gmasoln.com/members/mark-connolly/https://gmasoln.com/members/mark-connolly/Sat, 14 Oct 2023 15:23:53 +0000 https://gmasoln.com/members/rui-martin-msc/https://gmasoln.com/members/rui-martin-msc/Wed, 06 Sep 2023 14:06:36 +0000 https://gmasoln.com/members/hara-kousoulakou-msc/https://gmasoln.com/members/hara-kousoulakou-msc/Wed, 06 Sep 2023 14:00:51 +0000 https://gmasoln.com/members/ana-teresa-paquete-msc/https://gmasoln.com/members/ana-teresa-paquete-msc/Wed, 06 Sep 2023 14:00:02 +0000 https://gmasoln.com/publications/fiscal-impact-of-smoking-cessation-in-thailand-a-government-perspective-cost-benefit-analysis/https://gmasoln.com/publications/fiscal-impact-of-smoking-cessation-in-thailand-a-government-perspective-cost-benefit-analysis/Fiscal Impact of Smoking Cessation in Thailand: A Government Perspective Cost-Benefit AnalysisFri, 22 Feb 2019 12:57:50 +0000 https://gmasoln.com/publications/vaccination-programs-for-older-adults-in-an-era-of-demographic-change/https://gmasoln.com/publications/vaccination-programs-for-older-adults-in-an-era-of-demographic-change/Vaccination programs for older adults in an era of demographic changeFri, 22 Feb 2019 12:57:24 +0000 https://gmasoln.com/publications/327/https://gmasoln.com/publications/327/Economic Analysis of Vaccination Programs: An ISPOR Good Practices for Outcomes Research Task Force ReportFri, 22 Feb 2019 12:56:52 +0000 https://gmasoln.com/publications/journal-of-georgia-public-health-association-53-287-293/https://gmasoln.com/publications/journal-of-georgia-public-health-association-53-287-293/(2016). Weight status and satisfaction with healthcare received in the US and Georgia.Sun, 19 Mar 2017 14:50:46 +0000 https://gmasoln.com/publications/value-in-health-20-2-273-277/https://gmasoln.com/publications/value-in-health-20-2-273-277/ The fiscal consequences attributed to changes in morbidity and mortality linked to investments in health care: a government perspective analytic framework. Value in Health 20 (2), 273-277.Sat, 11 Mar 2017 12:07:18 +0000 https://gmasoln.com/publications/schey-c-krabbe-pfm-postma-mj-connolly-mp-v/https://gmasoln.com/publications/schey-c-krabbe-pfm-postma-mj-connolly-mp-v/ Multi-criteria decision analysis (MCDA): testing a proposed MCDA framework for orphan drugs. Sat, 11 Mar 2017 12:06:45 +0000 https://gmasoln.com/publications/connolly-mp-goodwin-e-schey-c-zummo-j/https://gmasoln.com/publications/connolly-mp-goodwin-e-schey-c-zummo-j/ Toxoplasmosis Encephalitis Relapse Rates with Pyrimethamine-based Therapy: Systematic Review and Meta-analysis. Sat, 11 Mar 2017 12:06:21 +0000 https://gmasoln.com/publications/setiawan-d-kotsopoulos-n-wilschut-jc-postma-mj-connolly-mp/https://gmasoln.com/publications/setiawan-d-kotsopoulos-n-wilschut-jc-postma-mj-connolly-mp/ Assessment of the broader economic consequences of HPV prevention from a government-perspective: A fiscal analytic approach. Sat, 11 Mar 2017 12:06:00 +0000 https://gmasoln.com/publications/connolly-mp-tashjian-c-kotsopoulos-n-bhatt-a-postma-mj/https://gmasoln.com/publications/connolly-mp-tashjian-c-kotsopoulos-n-bhatt-a-postma-mj/A comparison of average wages with age-specific wages for assessing indirect productivity losses: Analytic simplicity versus analytic precision.Sat, 11 Mar 2017 12:05:33 +0000 https://gmasoln.com/publications/health-economics-review-2015-523/https://gmasoln.com/publications/health-economics-review-2015-523/Quantifying the broader economic consequences of quadrivalent human papillomavirus (HPV) vaccination in Germany applying a government perspective framework. Sat, 11 Mar 2017 12:04:52 +0000 https://gmasoln.com/publications/journal-of-market-access-2-23897-2/https://gmasoln.com/publications/journal-of-market-access-2-23897-2/Is the gap between micro and macroeconomic assessments in health care well understood? The case of vaccination and potential remedies. Tue, 21 Feb 2017 20:06:45 +0000 https://gmasoln.com/publications/human-reproduction-20142961313-1329/https://gmasoln.com/publications/human-reproduction-20142961313-1329/Universal coverage of IVF pays off.Tue, 21 Feb 2017 20:05:59 +0000 https://gmasoln.com/publications/gastric-cancer-2014-2/https://gmasoln.com/publications/gastric-cancer-2014-2/Health utility of patients with advanced gastrointestinal stromal tumors (GIST) after failure of imatinib and sunitinib: findings from GRID, a randomized, double-blind, placebo-controlled phase III study of regorafenib versus placebo. Wed, 08 Feb 2017 03:01:51 +0000 https://gmasoln.com/publications/j-of-health-economics-and-outcomes-research-201313212-23-2/https://gmasoln.com/publications/j-of-health-economics-and-outcomes-research-201313212-23-2/Assessing the economic burden and benfit-cost of treating attention-deficit hyperactivity disorder in Germany.Sun, 05 Feb 2017 17:44:24 +0000 https://gmasoln.com/publications/orphanet-journal-of-rare-diseases-2014-922/https://gmasoln.com/publications/orphanet-journal-of-rare-diseases-2014-922/Estimating the budget impact of orphan rugs in Sweden and France 2013-2020.Sun, 05 Feb 2017 17:44:00 +0000 https://gmasoln.com/publications/ispor-connections-novemberdecember-2013196pp16-17/https://gmasoln.com/publications/ispor-connections-novemberdecember-2013196pp16-17/The Fiscal Consequences of Changes in Health Status: A ‘Government Perspective’ Modelling Framework. Sun, 05 Feb 2017 17:43:30 +0000 https://gmasoln.com/publications/vaccine-201331465430-4/https://gmasoln.com/publications/vaccine-201331465430-4/Fiscal consequences of changes in morbidity and mortality attributed to rotavirus immunisation.Sun, 05 Feb 2017 17:43:01 +0000 https://gmasoln.com/publications/j-of-health-economics-and-outcomes-research-201313212-23/https://gmasoln.com/publications/j-of-health-economics-and-outcomes-research-201313212-23/Assessing the Economic Burden and Benefit-cost of Treating Attention-deficit Hyperactivity Disorder in Germany.Sun, 05 Feb 2017 17:42:17 +0000 https://gmasoln.com/publications/j-of-crohns-and-colitis-in-press-2013/https://gmasoln.com/publications/j-of-crohns-and-colitis-in-press-2013/Cost and quality-adjusted life year differences in the treatment of active ulcerative colitis using once-daily 4 g or twice-daily 2 g mesalazine dosing.Sun, 05 Feb 2017 17:41:54 +0000 https://gmasoln.com/publications/the-journal-of-mental-health-policy-and-economics-201316127-33/https://gmasoln.com/publications/the-journal-of-mental-health-policy-and-economics-201316127-33/The Fiscal Consequences of ADHD in Germany: A Quantitative Analysis Based on Differences in Educational Attainment and Lifetime Earnings.Sun, 05 Feb 2017 17:40:51 +0000 https://gmasoln.com/publications/pharmacoeconomics-2012308681-695/https://gmasoln.com/publications/pharmacoeconomics-2012308681-695/The impact of rotavirus vaccination on discounted net tax revenue in Egypt: A government perspective analysis.Sun, 05 Feb 2017 17:40:08 +0000 https://gmasoln.com/publications/oral-presentation-eshre-related-press-coverage/https://gmasoln.com/publications/oral-presentation-eshre-related-press-coverage/Relationship between public reimbursement for assisted reproduction technologz and treatment practices based on evaluation of 2007 European IVF Monitoring (EIM) data. Sun, 05 Feb 2017 17:39:24 +0000 https://gmasoln.com/publications/netherlands-journal-of-medicine-2012-aug706272-7/https://gmasoln.com/publications/netherlands-journal-of-medicine-2012-aug706272-7/The economics of mesalazine in active ulcerative colitis and maintenance in The Netherlands.Sun, 05 Feb 2017 17:38:08 +0000 https://gmasoln.com/publications/orphanet-journal-of-rare-diseases-2011-662/https://gmasoln.com/publications/orphanet-journal-of-rare-diseases-2011-662/Estimating the budget impact of orphan medicines in Europe: 2010 - 2020.Sun, 05 Feb 2017 17:37:44 +0000 https://gmasoln.com/publications/related-scrip-article-orphan-drugs-wont-bankrupt-eu-healthcare-budgets-28-october-2011/https://gmasoln.com/publications/related-scrip-article-orphan-drugs-wont-bankrupt-eu-healthcare-budgets-28-october-2011/Related Scrip article: Orphan drugs won't bankruptSun, 05 Feb 2017 17:37:14 +0000 https://gmasoln.com/publications/am-j-blood-res-201112160-166/https://gmasoln.com/publications/am-j-blood-res-201112160-166/A review of anemia as a cardiovascular risk factor in patients with myelodysplastic syndromes.Sun, 05 Feb 2017 17:36:44 +0000 https://gmasoln.com/publications/doi-information-10-1016j-rbmo-2011-09-006/https://gmasoln.com/publications/doi-information-10-1016j-rbmo-2011-09-006/Cross-border reproductive care: market forces in action or market failure? An economic perspective. Reproductive BioMedicine Online. Accepted for publication.Sun, 05 Feb 2017 17:36:13 +0000 https://gmasoln.com/publications/int-immunopharmacol-20111191358-61/https://gmasoln.com/publications/int-immunopharmacol-20111191358-61/Kiovig for primary immunodeficiency: Reduced infusion and cost per infusion.Sun, 05 Feb 2017 17:35:55 +0000 https://gmasoln.com/publications/reprod-biomed-online-2011237830-7/https://gmasoln.com/publications/reprod-biomed-online-2011237830-7/The long-term fiscal impact of funding cuts to Danish public fertility clinics.Sun, 05 Feb 2017 17:35:34 +0000 https://gmasoln.com/publications/hum-reprod-update-2010166603-13/https://gmasoln.com/publications/hum-reprod-update-2010166603-13/GM; ESHRE Reproduction and Society Task Force. The costs and consequences of assisted reproductive technology: an economic perspective.Sun, 05 Feb 2017 17:35:04 +0000 https://gmasoln.com/publications/related-newsweek-article/https://gmasoln.com/publications/related-newsweek-article/Related Newsweek articleSun, 05 Feb 2017 17:33:41 +0000 https://gmasoln.com/publications/thesis-from-university-of-groningen-library-2010/https://gmasoln.com/publications/thesis-from-university-of-groningen-library-2010/The Economics of Assisted Reproduction: Costs and consequences of fertility treatments.Sun, 05 Feb 2017 17:33:03 +0000 https://gmasoln.com/publications/j-med-mark-20101015-14/https://gmasoln.com/publications/j-med-mark-20101015-14/Healthcare as an investment: Implications for an era of ageing populations.Sun, 05 Feb 2017 17:32:16 +0000 https://gmasoln.com/publications/journal-of-crohns-and-colitis-201043275-282/https://gmasoln.com/publications/journal-of-crohns-and-colitis-201043275-282/A comparison of physician-rated disease severity and patient reported outcomes in mild to moderately active ulcerative colitis.Sun, 05 Feb 2017 17:31:31 +0000 https://gmasoln.com/publications/nairobi-2-6-november-2009-poster-856/https://gmasoln.com/publications/nairobi-2-6-november-2009-poster-856/Assessing economic benefits for government and society attributed to malaria investment strategies: An exploratory analysis based on malaria vaccination. The Multilateral Initiative on Malaria (MIM),Sun, 05 Feb 2017 17:30:50 +0000 https://gmasoln.com/publications/reprod-biomed-online-2009196767-9/https://gmasoln.com/publications/reprod-biomed-online-2009196767-9/What's on the mind of IVF consumers?Sun, 05 Feb 2017 17:29:57 +0000 https://gmasoln.com/publications/pharmaceutical-marketing-feature-article-september-2009/https://gmasoln.com/publications/pharmaceutical-marketing-feature-article-september-2009/The potential economic benefit of maintaining a healthy workforce should be considered when valuing health technologies.Sun, 05 Feb 2017 17:29:32 +0000 https://gmasoln.com/publications/digestion-2009804241-6/https://gmasoln.com/publications/digestion-2009804241-6/Quality of life improvements attributed to combination therapy with oral and topical mesalazine in mild-to-moderately active ulcerative colitis.Sun, 05 Feb 2017 17:29:05 +0000 https://gmasoln.com/publications/hum-reprod-200924112796-800/https://gmasoln.com/publications/hum-reprod-200924112796-800/The impact of introducing patient co-payments in Germany on the use of IVF and ICSI: A price-elasticity of demand assessment.Sun, 05 Feb 2017 17:28:30 +0000